As of July 28, the US Centers for Disease Control and Prevention (CDC) reported 4,906 cases of monkeypox.
Of the 21,148 global cases reported so far, 20,804 have occurred in 71 countries that have “historically not reported” the disease.
They spread the rumor that monkeypox is a biological weapon
The World Health Organization (WHO) recently declared the outbreak a global health emergency.
As scientists investigate rise in cases, US anti-vaccine group child health care This fuels speculation that the outbreak of monkeypox is not natural.
In this sense, the organization, which is One of the main sources of anti-vaccine misinformationshared an excerpt from an interview with former biological warfare epidemiologist Meryl Ness on Twitter.
Interviewer was asking Why was it so early to license the monkeypox vaccine in 2019, “when there was no outbreak.”
Nass acknowledged that the vaccine is an older vaccine developed by the Danish company Bavarian Nordic.
But he still questioned why it only got Food and Drug Administration (FDA) approval until that year.
“Did they know what was coming?” He asked, referring to the outbreak.
The presenter said that “many people would jump to the conclusion” that the government “knew that monkeypox was coming”, and what could be reasonably asked whether the government had “spread” it.
Nas agreed, saying, “Monkeypox never spread like this.”
And he said: “Is this a type made in a lab?”
However, there is no evidence that this is the case, and speculation that the FDA’s approval of the 2019 vaccine suggests the government may have issued monkeypox because a bioweapon is overblown.
Endemic to Africa, discovered in Denmark
monkey poxEndemic to West and Central Africa, was first discovered in 1958 among monkeys in a Danish laboratory.
Despite the name, the natural hosts of the disease are probably rodents and other small mammals.
Monkeypox is part of the same family of viruses as smallpox and has similar symptoms, such as flu-like symptoms and sores.
Smallpox, which killed millions, was more contagious and deadly than monkeypox.
The last known natural case was recorded in 1977. Three years later, the World Health Assembly, the WHO’s apex body, announced its end.
Smallpox has since been present in laboratory research specimens and in the United States Strategic National Stockpile. adequate vaccination for its entire population.
Now, in 2019, nothing is hidden with the approval of the JYNNEOS vaccine by the FDA.
“Monkeypox has been associated with sporadic outbreaks in recent decades,” said FDA press officer Abby Capobianco. polygraph.info,
Because of their similarities, smallpox vaccines offer some protection against monkeypox.
As noted by the magazine smithsonianThe “decline in coverage of the smallpox vaccine” in Africa over the past three decades “coincides with dozens of monkeypox outbreaks and countless cases.”
For example, Nigeria experienced an outbreak in 2017, “nearly 40 years after the last reported case in the country.”
In June 2003, dozens of confirmed cases Monkeypox has been reported in six US states.
That outbreak was traced to a shipment of animals from Ghana to Texas. were also registered in 2021 cases imported into the country.
American Fears and Remedies
However, after the September 11, 2001 attacks and natural outbreaks, the fear of bioterrorism renewed concern by naturally occurring viruses such as smallpox.
It made the United States investment will increase in medicines and related vaccines.
However, the government should anticipate and prepare for a disaster, it does not indicate that it is a conspiracy.
Traditional smallpox vaccines can cause serious side effects. Instead, JYNNEOS contains a weakened strain of the vaccinia virus related to smallpox and monkeypox.
“JYNNEOS was developed as a safer alternative to the traditional smallpox vaccine for people with compromised immune systems,” he explained. polygraph.info Thomas Deutsch, communications partner of Bavarian Nordic.
“Development (of the vaccine) began in 2003, and since 2010 we have given the vaccine to the Strategic National Stockpile,” he said.
“Until 2019, it was never for monkeypox, but specifically for smallpox. However, since smallpox vaccines have also been shown to protect against monkeypox, the indication was expanded upon when the FDA granted its approval.
Although JYNNEOS received FDA approval in 2019 as a smallpox and monkeypox vaccine, Europe approved it as a smallpox vaccine in 2013.